A novel polyclonal antibody allows for more specific measurement of digoxin without cross-reactivity from its glycosidic metabolites.
May enable specific digoxin immunoassays in patients; animal data leave open clinical validation.
Current immunoassays for digoxin do not distinguish digoxin from its glycosidic metabolites. We have synthesized a novel digoxin/bovine serum albumin conjugate via reductive ozonolysis of the lactone ring such that the carbohydrate moiety of digoxin remains intact. Antibodies raised against this conjugate show minimal cross reactivity to digoxigenin, bisdigitoxide, monodigitoxide, digoxigenin, and digitoxin. With this antibody, digoxin can be measured in the presence of these metabolites.
No takes yet. Share an insight, caveat, or question.
Thong et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: